Drawing for SEQUEL

USPTO serial 99021112

SEQUEL

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
FRIZALONE, SARAH O
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with SEQUEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
009lenses for eyeglasses; spectacle lenses with prism lenses; contoured prism eyeglass lenses used to alleviate symptoms of misalignment and to provide relief for hard-working eyes; lenses for eyeglasses used to relieve symptoms of eyestrain resulting from use of digital devices; eyeglasses used to relieve the symptoms of eye fatigue, headaches, neck pain, and shoulder pain; eye glasses for use with computers; eye glasses for use with digital screens; eyeglasses with progressive prism lenses; eyeglasses used to treat trigeminal dysphoria; progressive eyeglass lenses with contour prism; eye glasses for use in officesACTIVE—
010Diagnostic apparatus for diagnosing eye diseases and dysfunctions for medical use; optometric instruments for determining eye misalignment and vergence insufficiency; apparatus to diagnose strabismus for prism to be implemented in spectacle lenses for medical purposes; apparatus for measuring and diagnosing strabismus, trigeminal dysphoria, vergence insufficiency and ocular misalignment in order to determine prescription for contoured prism eyeglass lenses to alleviate symptoms of misalignment and to provide relief for hard-working eyes for medical purposes; apparatus for measuring and diagnosing strabismus, trigeminal dysphoria and ocular misalignment in order to determine lens prescription for eyeglasses to relieve symptoms of eyestrain resulting from use of digital devices for medical purposes; apparatus for measuring and diagnosing strabismus, trigeminal dysphoria, vergence insufficiency and ocular misalignment in order to determine eyeglass prescription to relieve the symptoms of eye fatigue, headaches, neck pain, and shoulder pain for medical purposes; optometric measurement instrument to determine prescription for computer glasses and digital glasses prism by measuring ocular misalignment for medical purposes; apparatus for measuring and diagnosing trigeminal dysphoria in order to determine lens prescription to treat trigeminal dysphoria for medical purposes; optometric measurement instrument to assist the prescription of contact lenses with prism and contour prism by measuring ocular misalignment for medical purposes; optometric instrument for measuring ocular motility for medical purposes; optometric instrument for pupillometry for medical purposes; optometric instrument for measuring afferent pupillary response for medical purposes; optometric instrument for assessing saccadic eye movement for medical purposes; optometric instrument for measuring smooth pursuits of the eye for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2026EX1GSOU EXTENSION 1 GRANTED—
May 15, 2026EXT1SOU EXTENSION 1 FILED—
May 15, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 8, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 27, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 27, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 25, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 25, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Aug 25, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 25, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 25, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 15, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2025DOCKASSIGNED TO EXAMINER—
Jan 28, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 28, 2025NWAPNEW APPLICATION ENTERED—
Jan 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance